Avid Bioservices Inc (CDMO)

[alvaroc2]

Safety and Efficacy Study of AMG 531 to Treat ITP in Pediatric
2011-03-02 14:01:06.433 GMT

Status Change : Active, not recruiting to Completed

Summary

The purpose of this study is to evaluate the safety and tolerability of AMG
531 in the treatment of thrombocytopenia in pediatric subjects with chronic ITP. We will also evaluate the efficacy of AMG 531 and characterize the pharmacokinetics of AMG 531. It is anticipated that AMG 531, when given at an effective dose and schedule, will be well tolerated treatment for thrombocytopenia among pediatric subjects with chronic ITP.

Study of Bavituximab in Patients With Advanced Solid Tumor
2011-03-02 14:01:18.560 GMT

Status Change : Active, not recruiting to Completed

Summary

The purpose of this study is to determine the safety of bavituximab when administered via a vein, and to examine how bavituximab behaves in the body - how quickly it is taken up by the body and how long it stays there. The effect of bavituximab on tumor responses will also be examined.